NCT06764797

Brief Summary

This study will investigate whether combining virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 19, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

1.7 years

First QC Date

January 2, 2025

Last Update Submit

January 2, 2025

Conditions

Keywords

Virtual reality, Mirror therapy, non invasive brain stimulation, tDCS, stroketranscranial direct current stimulation

Outcome Measures

Primary Outcomes (4)

  • Fugl-Mayer Upper limb assessment (FMA)

    FMA is a performance-based impairment measure particular to strokes, designed to assess motor functioning, balance, sensory, and joint functionality. It consists of five domains, which have 155 total items. The full potential scale score is 226. Scale items are scored based on the ability to finish the item using a 3-point ordinal scale. Motor score: from 0 to 100, 66 points for the upper extremity and 34 points for the lower extremities.

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • Wolf motor function test (WMT)

    WMT, consisting of timed and practical tasks, measures the motor function of the upper extremity (UE). The WMFT has 17 items in the most common version. The first six items involved timed functional tasks; items 7 and 14 were strength tests, and the final nine analyzed the participants' movement quality while carrying out various tasks. Items scored on a 6-point scale, with lower scores indicating lower levels of functioning.

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • box and blocks test (BBT)

    BBT assesses manual dexterity of the hand. It requires subjects to lift and release 2.5 cm³ cubes to move them from one compartment to another. BBT comprises 150 blocks. The test should begin with the unaffected upper limb to practice and record baseline values. The score is defined as the number of blocks transferred correctly within 60 seconds.

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • Nine-Hole Peg Test (NHPT)

    NHPT was developed to assess finger dexterity. It is made up of a nine-peg square board. The board has holes on one end for the pegs to fit into, and it also has a shallow circular dish on the other for storing the pegs. The patient is instructed to quickly insert the pegs into the holes on the board after taking each one out of a container as part of the NHPT. Then, one by one, clients must bring the pegs out of the holes and put them back into the container. Scoring is according to how long it took them to finish the test activity, measured in seconds.

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

Secondary Outcomes (3)

  • Stroke impact scale-16 (SIS-16)

    at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  • transcranial magnetic stimulation (TMS)

    at baseline, and after intervention ( 4 weeks).

  • Functional magnetic resonance imaging (fMRI)

    at baseline, and after intervention ( 4 weeks).

Study Arms (4)

anodal tDCS combined with VRMT

EXPERIMENTAL

20 minutes of anodal tDCS combined with 45 minutes of VRMT

Device: Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy

Anodal tDCS alone

ACTIVE COMPARATOR

20 minutes of anodal tDCS alone

Device: Transcranial Direct Current Stimulation

VRMT alone, Sham tDCS

ACTIVE COMPARATOR

45 minutes of VRMT alone, For the sham-tDCS, the current flow will be terminated after 30 seconds.

Device: Virtual reality

Conventional Physical therapy alone, Sham tDCS

SHAM COMPARATOR

45 minutes of conventional physical therapy, For the sham-tDCS, the current flow will be terminated after 30 seconds.

Other: Conventional physical therapy

Interventions

tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.

Anodal tDCS alone

The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.

VRMT alone, Sham tDCS

20 minutes of tDCS during 45 minutes of VRMT games.

anodal tDCS combined with VRMT

45 minutes of conventional physical therapy with sham tDCS

Conventional Physical therapy alone, Sham tDCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old.
  • Stroke patients with unilateral cerebral infarction or hemorrhage, more than three months following the stroke.
  • Adequate cognitive ability to follow instructions (The Arabic version of the Mini-Mental State Examination scores \> 24).
  • Modified Ashworth scale score \< 3.
  • Fugl-Meyer Assessment (FMA) score of 10-58 indicating moderate-to-severe arm impairment.

You may not qualify if:

  • visual impairment and field defect or hemi-sensory inattention and unilateral neglect.
  • Wernicke's aphasia, or global aphasia, leads to difficulty following instructions.
  • Any contraindication to NIBS.
  • Other neurological conditions or participation in another study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

King fahad medical city

Riyadh, Riyadh Region, 11461, Saudi Arabia

RECRUITING

King Khalid University Hospital

Riyadh, Riyadh Region, 11461, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Alaa M. Albishi, Doctor of Philosophy

    King Saud University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Alaa M. Albishi, Assistant Professor

CONTACT

Dr. Ahmad O Alokaily, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 8, 2025

Study Start

September 19, 2023

Primary Completion

May 31, 2025

Study Completion

July 21, 2025

Last Updated

January 8, 2025

Record last verified: 2025-01

Locations